Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Recruiting · NCT05426252 · Registry updated 2023-12-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Recruiting | Phase 1 / Phase 2 | 2023-12-19 | NCT05426252 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Thalassemia Foundation of Canada | 1 |
| The Hospital for Sick Children | 162 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yogi Chopra | Toronto | Canada | 1 |